US Stock MarketDetailed Quotes
LFCR Lifecore Biomedical
- 7.310
- +0.330+4.73%
Close Nov 22 16:00 ET
- 7.310
- 0.0000.00%
Post 20:01 ET
269.21MMarket Cap52.21P/E (TTM)
7.455High7.055Low207.49KVolume7.140Open6.980Pre Close1.51MTurnover0.95%Turnover Ratio22.84P/E (Static)36.83MShares8.90052wk High-68.32P/B160.45MFloat Cap3.67952wk Low--Dividend TTM21.95MShs Float16.750Historical High--Div YieldTTM5.73%Amplitude1.510Historical Low7.280Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Lifecore Biomedical Stock Forum
Dow Jones· 1 min ago
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update
Lifecore Biomedical (NASDAQ: LFCR) reported its fiscal year 2024 results, showing strong revenue growth of 24.2% to $128.3 million.
The company's CDMO business grew 27%, while its HA raw material manufacturing increased 18%.
Gross profit rose 49.5% to $41.9 million, with margin expanding to 32.6%.
Key highlights include:
Net income from con...
$American International Group (AIG.US)$ $Bioventus (BVS.US)$ $CohBar (CWBR.US)$ $HeartCore Enterprises (HTCR.US)$ $Intuit (INTU.US)$ $Lifecore Biomedical (LFCR.US)$ $Lipocine (LPCN.US)$ $Microbot Medical (MBOT.US)$ $Ocean Biomedical (OCEA.US)$ $Palo Alto Networks (PANW.US)$ $RenaissanceRe Holdings (RNR.US)$ $SunCar technology (SDA.US)$ $Sysco Corp (SYY.US)$ $TEMA MONOPOLIES AND OLIGOPOLIES ETF (TOLL.US)$ $Western Digital (WDC.US)$
150M$ refinancing deal
No comment yet